Clinical Trials Browser

Phase 2 × epigallocatechin gallate × 90 days × Clear all

NCT07572396 2026-05-14

Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities

Phase 2 Recruiting

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia, Papillomavirus Infections, Atypical Squamous Cells of the Cervix

NCT04553666 2026-05-07

ReFOCUS1

Phase 2 Completed

24 enrolled 17 charts

Frailty, Inflammation

NCT06068543 2026-03-06

ReFOCUS2

Phase 2 Recruiting

Frailty, Inflammation